Source:http://linkedlifedata.com/resource/pubmed/id/12073130
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-6-19
|
pubmed:abstractText |
Porcine parvovirus (PPV) virus-like particles (VLPs) constitute a potential vaccine for prevention of parvovirus-induced reproductive failure in gilts. Here we report the development of a large scale (25 l) production process for PPV-VLPs with baculovirus-infected insect cells. A low multiplicity of infection (MOI) strategy was efficiently applied avoiding the use of an extra baculovirus expansion step. The optimal harvest time was defined at 120 h post-infection at the MOI used, with the cell concentration at infection being 1.5x10(6) cells/ml. An efficient purification scheme using centrifugation, precipitation and ultrafiltration/diafiltration as stepwise unit operations was developed. The global yield of the downstream process was 68%. Baculovirus inactivation with Triton X-100 was successfully integrated into the purification scheme without an increase in the number of process stages. Immunogenicity of the PPV-VLPs tested in guinea pigs was similar to highly purified reference material produced from cells cultured in the presence of serum-containing medium. These results indicate the feasibility of industrial scale production of PPV-VLPs in the baculovirus system, safety of the product, and the potency of the product for vaccine application.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0175-7598
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
59
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-50
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12073130-Animals,
pubmed-meshheading:12073130-Antibodies, Viral,
pubmed-meshheading:12073130-Baculoviridae,
pubmed-meshheading:12073130-Cells, Cultured,
pubmed-meshheading:12073130-Culture Media, Serum-Free,
pubmed-meshheading:12073130-Feasibility Studies,
pubmed-meshheading:12073130-Guinea Pigs,
pubmed-meshheading:12073130-Immunization Schedule,
pubmed-meshheading:12073130-Parvovirus, Porcine,
pubmed-meshheading:12073130-Spodoptera,
pubmed-meshheading:12073130-Technology, Pharmaceutical,
pubmed-meshheading:12073130-Vaccination,
pubmed-meshheading:12073130-Vaccines, Synthetic,
pubmed-meshheading:12073130-Viral Vaccines,
pubmed-meshheading:12073130-Virion
|
pubmed:year |
2002
|
pubmed:articleTitle |
Large scale production and downstream processing of a recombinant porcine parvovirus vaccine.
|
pubmed:affiliation |
Instituto de Biologia Experimental e Tecnológica/Instituto de Tecnologia Química e Biológica IBET/ITQB, Apartado 12, 2781-901 Oeiras, Portugal.
|
pubmed:publicationType |
Journal Article
|